Clinical Trial Update: An Integrative-"Omics" Study of Cardiomyopathy Patients for Diagnosis and Prognosis in China

View source ↗

Summary

A clinical trial in China is exploring an integrative 'omics' approach to diagnose and prognosticate various forms of cardiomyopathy, including dilated and hype…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmogenic Right Ventricular Cardiomyopathy
• Dilated Cardiomyopathy
• Hypertrophic Cardiomyopathy
• Left Ventricular Non-compaction Cardiomyopathy
• Restrictive Cardiomyopathy

Snippet

Sponsor: Beijing Institute of Heart, Lung and Blood Vessel Diseases | Conditions: Dilated Cardiomyopathy, Hypertrophic Cardiomyopathy | Status: UNKNOWN